Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Steven Goldberg

Orthopaedic Surgery Naples, FL Medical Doctor

NPI 1447202049 CMS profile 201543

6376 Pine Ridge Rd Ste 430, Naples, FL 34119

Open in the dashboard

General payments

$131,473

88 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$46,306,075

6 holdings reported · through program year 2025

Through program year 2025, Steven Goldberg of Naples, FL is reported in the CMS Open Payments database as having received $131,473 across 88 general payments and $0 in research payments paid to them. They also declared ownership or investment interests valued at $46,306,075 across 6 holdings.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 93rd percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

13 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $121,823 19
2024 General $1,852 17
2023 General $2,228 21
2022 General $1,483 10
2021 General $203 7
2020 General $225 3
2019 General $3,660 11
2025 Ownership $3,042,892 1
2023 Ownership $3,012,892 1
2022 Ownership $11,593,634 1
2021 Ownership $10,321,304 1
2020 Ownership $9,219,737 1
2019 Ownership $9,115,616 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Steven Goldberg
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to Steven Goldberg were reported at $121,823. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year Steven Goldberg Orthopaedic Surgery median Middle half National median
2019 $3,660 $644 $140–$2,844 $163
2020 $225 $312 $75–$1,860 $114
2021 $203 $520 $117–$2,495 $132
2022 $1,483 $598 $128–$2,731 $149
2023 $2,228 $461 $128–$2,264 $160
2024 $1,852 $497 $134–$2,475 $164
2025 $121,823 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Catalyst OrthoScience $130,410 70 payments
  2. Zimmer Biomet Holdings, Inc. $579 9 payments
  3. Stryker Corporation $226 1 payment
  4. Orthalign Inc $101 1 payment
  5. Arthrex, Inc. $51 1 payment
  6. Smith+Nephew, Inc. $35 1 payment
  7. Heraeus Medical, LLC. $34 3 payments
  8. Abbott Laboratories $22 1 payment
  9. Nevro Corp. $15 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $116,161 12 payments
  2. Travel and Lodging $10,278 15 payments
  3. Food and Beverage $5,034 61 payments
Products named General payments · program years 2019–2025
  1. Catalyst Total CSR $5,192 21 payments
  2. CSR & R1 Reverse Total Shoulder Systems $1,762 15 payments
  3. R1 Reverse Total Shoulder $1,762 15 payments
  4. Archer 3D Software $1,690 14 payments
  5. Catalyst CSR Shoulder System $1,593 13 payments
  6. R1 Reverse Shoulder System $1,226 9 payments
  7. COMPREHENSIVE $249 2 payments
  8. PANGEA $226 1 payment
  9. Catalyst TSR $210 2 payments
  10. Trabecular Metal $119 1 payment
  11. Other $579 16 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 50 billing codes

Paid by Medicare

$634,862

Of which drugs: $19,313

Medicare patients

1,369

Average age 76

Services billed

18,014

711 women, 658 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 75%
High blood pressure 72%
Ischemic heart disease 39%
Chronic kidney disease 21%
Osteoporosis 21%
Diabetes 20%
Cancer 20%
Depression 20%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose J7324 Office 41 175 $17,257
Injection, methylprednisolone acetate, 1 mg J1010 Office 279 13,606 $1,384
Injection, methylprednisolone acetate, 40 mg J1030 Office 141 156 $665

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

88 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record